News: Ranbaxy asks 18 top execs to leave

C-Suite

Ranbaxy asks 18 top execs to leave

The order comes a year after the Dilip Shanghvi-led firm acquired Ranbaxy in an all-stock deal and a few weeks after Q4 profits shrank 44 per cent due to costs incurred in assimilating the buyout and regulatory issues.

Sun PharmaBSE 0.38 % has asked 18 top executives of Ranbaxy Labs to leave the firm in one of the biggest culls of senior management professionals in recent times. The order comes a year after the Dilip Shanghvi-led firm acquired Ranbaxy in an all-stock deal and a few weeks after Q4 profits shrank 44 per cent due to costs incurred in assimilating the buyout and regulatory issues. 

Read Economic Times full story here.

Read full story

Topics: C-Suite, #Corporate, #Jobs

Did you find this story helpful?

Author

QUICK POLL

What is your top focus area for reinventing work in the hybrid world of work?

How can we prepare for a challenging 2023?

READ our latest issue for tips and suggestions.